GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Affymax, Inc. (AFFY) [hlAlert]

Rating:
Mkt Outperform
AFFY
down 99.51 %

Affymax, Inc. (AFFY) rated Mkt Outperform by JMP Securities

Posted on: Friday,  Feb 8, 2013  8:25 AM ET by JMP Securities

JMP Securities rated Mkt Outperform Affymax, Inc. (OTCBB: AFFY) on 02/08/2013, when the stock price was $17.70.
Since then, Affymax, Inc. has lost 99.51% as of 08/27/2015's recent price of $0.09.
If you would have followed this JMP Securities's recommendation on AFFY, you would have lost 99.51% of your investment in 930 days.

Affymax, Inc. is a biopharmaceutical company developing peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The Company's product candidate, Hematide, is designed to treat anemia associated with chronic renal failure. Hematide is a relatively small synthetic peptide-based erythropoiesis stimulating agent (ESA), which it is developing for the treatment of anemia patients with chronic renal failure. The Company is conducting Phase III clinical trials in patients suffering from chronic renal renal failure, on dialysis and not on dialysis (pre-dialysis). In August 2008, the Company and Takeda Pharmaceutical Company Limited (Takeda), agreed to suspend development of Hematide to treat chemotherapy induced anemia.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/8/2013 8:25 AM Buy
None
17.70
as of 12/13/2013
1 Week down  -3.46 %
1 Month down  -3.46 %
3 Months down  -43.74 %
1 YTD down  -95.20 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy